Related Experiment Video
Updated: Mar 19, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
Mucoepidermoid Carcinoma - Unknown Primary Affecting the Neck
Reinhard E Friedrich1, Jozef Zustin2
1Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany rfriedrich@uke.de.
Anticancer Research
|June 9, 2016
Summary
This report details successful treatment of a neck mucoepidermoid carcinoma of unknown primary. The patient remained cancer-free for 43 months, showing effective therapy for this rare condition.
Area of Science:
- Oncology
- Head and Neck Surgery
- Radiation Oncology
Background:
- Mucoepidermoid carcinoma (MEC) is a common salivary gland malignancy.
- Carcinoma of unknown primary (CUP) presents a diagnostic and therapeutic challenge.
- Localized neck swelling can indicate metastatic disease or a primary tumor.
Observation:
- A patient presented with localized neck swelling, diagnosed as mucoepidermoid carcinoma.
- Extensive staging failed to identify a primary tumor site, classifying it as CUP.
- Treatment involved modified neck dissection, chemotherapy, and fractionated radiotherapy.
Findings:
- The patient achieved a 43-month disease-free survival post-treatment.
- No local tumor recurrence or distant metastasis was observed.
- This case highlights a positive outcome for a rare presentation of MEC-CUP.
Implications:
- Combined modality treatment can be effective for mucoepidermoid carcinoma of unknown primary.
- Further research is needed to clarify the prognosis for MEC-CUP.
- Early diagnosis and comprehensive staging are crucial for managing neck malignancies.
